| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/27/1996 | WO1996019183A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | WO1996013179A3 Nutrient supplement compositions providing physiologic feedback |
| 06/27/1996 | DE4447361A1 Biozide Alkohole, ihre Herstellung und ihre Verwendung Biocides alcohols, their preparation and their use |
| 06/27/1996 | DE4446600A1 Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen Transdermal absorption of drugs from undercooled melts |
| 06/27/1996 | DE4445728A1 Verwendung von Boswelliasäure zur Behandlung von Hirntumoren Use of boswellic acid for the treatment of brain tumors |
| 06/27/1996 | CA2208485A1 Method for protecting the heart from ischemia |
| 06/27/1996 | CA2208268A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | CA2208211A1 E2-binding proteins |
| 06/27/1996 | CA2208088A1 Antifungal treatment of nails |
| 06/27/1996 | CA2206059A1 Improved cyclic crf antagonists |
| 06/27/1996 | CA2205863A1 Liposome eye drops |
| 06/26/1996 | EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent |
| 06/26/1996 | EP0717635A1 Methods for regulating gastrointestinal motility |
| 06/26/1996 | EP0717633A1 Growth differentiation factor-7 |
| 06/26/1996 | EP0717631A1 Immunomodulating compositions from bile |
| 06/26/1996 | EP0717625A1 A method of treating liver disease and like indications with vasodilating agents |
| 06/26/1996 | EP0717624A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
| 06/26/1996 | EP0717619A1 Treatment of adverse effects associated with administration of extracellular hemoglobin |
| 06/26/1996 | EP0717592A1 Method and composition for the treatment of apathy-amotivation syndrome |
| 06/26/1996 | EP0696201A4 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 06/26/1996 | CN1125402A Potassium channel blocking compounds and their use |
| 06/25/1996 | US5529992 Method for inhibiting myocardial fibrosis by administering an aldosterone antagonist which suppresses aldoster one receptors |
| 06/25/1996 | US5529771 Leukoregulin anti-herpes treatment |
| 06/20/1996 | WO1996018738A2 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES |
| 06/20/1996 | WO1996018649A1 Improved cyclic crf agonists |
| 06/20/1996 | WO1996018415A1 Selective and non-invasive visualization or treatment of vasculature |
| 06/20/1996 | WO1996018413A1 Carcinoma treatment |
| 06/20/1996 | WO1996018405A1 Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction |
| 06/20/1996 | WO1996018403A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 06/20/1996 | WO1996018398A1 Treatment of toxoplasmosis |
| 06/20/1996 | WO1996018382A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
| 06/20/1996 | WO1996018381A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| 06/20/1996 | WO1996018380A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations |
| 06/20/1996 | WO1996018379A1 Cosmetic and dermatological preparations with flavonoids |
| 06/20/1996 | WO1996015234A3 Lipid-splitting enzyme |
| 06/20/1996 | CA2207911A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 06/20/1996 | CA2207581A1 Probin tyrosine kinase (pyk2) its cdna cloning and its uses |
| 06/20/1996 | CA2207576A1 Improved cyclic crf agonists |
| 06/20/1996 | CA2183598A1 Treatment of toxoplasmosis |
| 06/19/1996 | EP0716847A1 Cosmetic or dermatologic compositions containing cinnamic acid derivatives and a flavonoid |
| 06/19/1996 | EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 06/19/1996 | EP0716606A1 Phosphate-binding polymers for oral administration |
| 06/19/1996 | EP0716603A1 Methods and compositions for inhibiting uridine secretion |
| 06/19/1996 | EP0605504B1 Cosmetic and dermatological preparations |
| 06/19/1996 | EP0578732B1 Chewable antacid compositions |
| 06/19/1996 | EP0563134B1 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| 06/19/1996 | CN1124926A Pyrazolopyrimidinones for the treatment of impotence |
| 06/18/1996 | US5527799 HIV protease inhibitors useful for the treatment of AIDS |
| 06/18/1996 | US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics |
| 06/13/1996 | WO1996017953A2 Genetic basis of factor xiii activity |
| 06/13/1996 | WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 06/13/1996 | WO1996017624A1 Sunscreen-wound healing composition |
| 06/13/1996 | WO1996017621A1 Correcting biological information transfer using three biological information blocks |
| 06/13/1996 | WO1996011021A3 Treatment of tissues to reduce subsequent response to injury |
| 06/13/1996 | WO1996009038A3 Alteration of activity and/or levels of haem-oxygenase to control inflammation |
| 06/13/1996 | DE19514522C1 Sauerstoffanionradikale enthaltende therapeutische Mittel und deren Verwendung zur Schmerzbehandlung Sauerstoffanionradikale containing therapeutic agents and their use for the treatment of pain |
| 06/13/1996 | CA2204994A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma |
| 06/12/1996 | EP0715855A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
| 06/12/1996 | EP0715853A1 Use of glutathione esters for the treatment of pulmonary diseases |
| 06/12/1996 | EP0715628A1 Substituted azaindolylidene compounds and process for their preparation |
| 06/12/1996 | EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity |
| 06/12/1996 | CN1124138A Compositions for treatment of diabetic complications |
| 06/11/1996 | US5525347 Beta-adrenergic receptor blocking compound and antidiaphoretic compound |
| 06/11/1996 | US5525338 Detection and therapy of lesions with biotin/avidin conjugates |
| 06/06/1996 | WO1996017054A1 Method and compositions for reducing cholesterol absorption |
| 06/06/1996 | WO1996016680A1 Phosphocholine drug derivatives |
| 06/06/1996 | WO1996016675A2 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 06/06/1996 | WO1996016664A1 Compositions for the treatment of parasitic and fungal infections |
| 06/06/1996 | WO1996016647A2 Use of chloride channel blockers for reducing intraocular pressure |
| 06/06/1996 | WO1996016644A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION |
| 06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 06/06/1996 | CA2206526A1 Method and compositions for reducing cholesterol absorption |
| 06/06/1996 | CA2206511A1 Compositions for the treatment of parasitic and fungal infections |
| 06/06/1996 | CA2206123A1 Use of chloride channel blockers for reducing intraocular pressure |
| 06/06/1996 | CA2204902A1 Phosphocholine drug derivatives |
| 06/05/1996 | EP0714663A2 Potentiation of drug response by a serotonin 1A receptor antagonist |
| 06/05/1996 | EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 06/05/1996 | EP0714407A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 06/05/1996 | EP0714300A1 Methods for modulating the human sexual response |
| 06/05/1996 | EP0714295A1 Fibrinogen receptor antagonists |
| 06/05/1996 | EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 06/04/1996 | US5523492 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 06/04/1996 | US5523301 Topically applying adrenergic blocking agent to eye to maintain retinal nerve fiber layer thickness, increase axoplasmic flow and decrease optic disc cupping and pallor; prophylaxis |
| 05/30/1996 | WO1996016179A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 05/30/1996 | WO1996016049A1 OXAZOLE DERIVATIVES AS ANTAGONISTS OF α-1C ADRENERGIC RECEPTORS |
| 05/30/1996 | WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 05/30/1996 | WO1996015782A1 A method for treating vascular headaches |
| 05/30/1996 | WO1996015771A1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 05/30/1996 | WO1996015669A1 Prophylactic treatment of allergic contact dermatitis |
| 05/30/1996 | WO1996011005A3 Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases |
| 05/30/1996 | CA2205920A1 Prophylactic treatment of allergic contact dermatitis |
| 05/30/1996 | CA2205860A1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 05/30/1996 | CA2205593A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 05/29/1996 | EP0713698A2 Medical use of atypical beta-adrenoceptor agonists |
| 05/29/1996 | EP0713390A1 Gelatin capsules containing a highly concentrated acetaminophen solution |
| 05/29/1996 | CA2163840A1 Potentiation of drug response |
| 05/28/1996 | US5521297 Nucleic acids encoding human metabotropic glutamate receptors |
| 05/28/1996 | US5521161 Method of treating HIV in humans by administration of ddI and hydroxycarbamide |
| 05/28/1996 | US5520920 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| 05/28/1996 | CA2078996C A bifunctional dtpa-type ligand |